Open main menu

Anti-Angiogenesis Therapy Using Thalidomide in Multiple Myeloma (Q62110902)

clinical trial
edit
Language Label Description Also known as
English
Anti-Angiogenesis Therapy Using Thalidomide in Multiple Myeloma
clinical trial

    Statements

    UARK 98-003, A Phase II Pilot Study of Anti-Angiogenesis Therapy Using Thalidomide in Patients With Multiple Myeloma (English)
    0 references
    February 1998
    0 references
    250
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit